chr2-201160763-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_003879.7(CFLAR):c.1125G>A(p.Val375Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00202 in 1,614,100 control chromosomes in the GnomAD database, including 75 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0021 ( 8 hom., cov: 31)
Exomes 𝑓: 0.0020 ( 67 hom. )
Consequence
CFLAR
NM_003879.7 synonymous
NM_003879.7 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.317
Publications
3 publications found
Genes affected
CFLAR (HGNC:1876): (CASP8 and FADD like apoptosis regulator) The protein encoded by this gene is a regulator of apoptosis and is structurally similar to caspase-8. However, the encoded protein lacks caspase activity and appears to be itself cleaved into two peptides by caspase-8. Several transcript variants encoding different isoforms have been found for this gene, and partial evidence for several more variants exists. [provided by RefSeq, Feb 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 2-201160763-G-A is Benign according to our data. Variant chr2-201160763-G-A is described in ClinVar as [Benign]. Clinvar id is 773850.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.317 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAdExome4 allele frequency = 0.00201 (2934/1461840) while in subpopulation AMR AF = 0.0395 (1766/44718). AF 95% confidence interval is 0.038. There are 67 homozygotes in GnomAdExome4. There are 1257 alleles in the male GnomAdExome4 subpopulation. Median coverage is 35. This position passed quality control check.
BS2
High AC in GnomAd4 at 322 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFLAR | NM_003879.7 | c.1125G>A | p.Val375Val | synonymous_variant | Exon 9 of 10 | ENST00000309955.8 | NP_003870.4 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00212 AC: 322AN: 152142Hom.: 8 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
322
AN:
152142
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00723 AC: 1817AN: 251352 AF XY: 0.00534 show subpopulations
GnomAD2 exomes
AF:
AC:
1817
AN:
251352
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00201 AC: 2934AN: 1461840Hom.: 67 Cov.: 35 AF XY: 0.00173 AC XY: 1257AN XY: 727238 show subpopulations
GnomAD4 exome
AF:
AC:
2934
AN:
1461840
Hom.:
Cov.:
35
AF XY:
AC XY:
1257
AN XY:
727238
show subpopulations
African (AFR)
AF:
AC:
9
AN:
33478
American (AMR)
AF:
AC:
1766
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26136
East Asian (EAS)
AF:
AC:
742
AN:
39698
South Asian (SAS)
AF:
AC:
5
AN:
86258
European-Finnish (FIN)
AF:
AC:
7
AN:
53416
Middle Eastern (MID)
AF:
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
327
AN:
1111974
Other (OTH)
AF:
AC:
78
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
196
391
587
782
978
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00211 AC: 322AN: 152260Hom.: 8 Cov.: 31 AF XY: 0.00210 AC XY: 156AN XY: 74444 show subpopulations
GnomAD4 genome
AF:
AC:
322
AN:
152260
Hom.:
Cov.:
31
AF XY:
AC XY:
156
AN XY:
74444
show subpopulations
African (AFR)
AF:
AC:
40
AN:
41540
American (AMR)
AF:
AC:
206
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
48
AN:
5188
South Asian (SAS)
AF:
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
AC:
1
AN:
10616
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
26
AN:
68020
Other (OTH)
AF:
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
17
34
50
67
84
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
17
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jun 06, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.